ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe

A. L. Rich, D. R. Baldwin, P. Beckett, et al.

Source: Guideline 2018
Number: 2018

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. L. Rich, D. R. Baldwin, P. Beckett, et al.. ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe. Guideline 2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERS Taskforce harmonised standards for lung cancer (LC) registration in Europe and the current Greek screenshot;Is it a long way to Tipperary?
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

The European initiative for quality management in lung cancer care
Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines
Year: 2014



The European initiative for quality management in lung cancer care
Source: Eur Respir J 2014; 43: 1254-1277
Year: 2014



The European initiative for quality management in lung cancer care
Source: Guideline 2014
Year: 2014

The approach to the surgical management of cancer in four European countries
Source: Eur Respir J 2003; 22: 838-844
Year: 2003



Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting?
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Chemotherapy for lung cancer in Scotland: a national survey
Source: Eur Respir J 2002; 20: Suppl. 38, 465s
Year: 2002

Clinical management of lung cancer in France: a national survey
Source: Eur Respir J 2001; 18: Suppl. 33, 228s
Year: 2001

Re-audit of adherence to NICE guidelines on investigation of lung cancer
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


Health inequalities in Europe: the situation for lung cancer
Source: Annual Congress 2012 - Update on Tallinn summit: health inequalities in Europe
Year: 2012


Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Assessing the local impact of a national lung cancer awareness campaign
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013



Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

The influence of the UK national lung cancer campaign on fast-track referrals to secondary care
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013


Case-mix adjusted outcomes in the national lung cancer audit in England
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


ESR/ERS statement paper on lung cancer screening
Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019
Year: 2020



ESR/ERS statement paper on lung cancer screening
Source: Guideline 2020
Year: 2020

The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


Chronic respiratory diseases and lung cancer research: a perspective from the European Union
Source: Eur Respir J 2015; 46: 1270-1280
Year: 2015